Read CTM CRC's Exit Report
Read CTM CRC's 2018 Annual Report
Stem cell & regenerative medicine company, Cynata, announce positive MSC efficacy data from preclinical trials
ADELAIDE scientists are leading the charge to cure all kinds of cancer, not just blood cancer.
Find out about CTM CRC's new translational facility
Integrated solutions for cost-effective, accessible cell therapies
CTM CRC Exit Report...
Integrated solutions for cost effective, accessible cell therapies
Creating industry-ready graduates
© 2019 CTM CRC